| European Case Law Identifier: | ECLI:EP:BA:2007:T022305.20070424 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 24 April 2007 | ||||||||
| Case number: | T 0223/05 | ||||||||
| Application number: | 97920213.2 | ||||||||
| IPC class: | C07D 239/94 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Irreversible inhibitors of tyrosine kinases | ||||||||
| Applicant name: | Warner-Lambert Company LLC | ||||||||
| Opponent name: | Wyeth | ||||||||
| Board: | 3.3.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Main request: Novelty (no) - Article 69 EPC not applicable for distinguishing the claimed subject-matter from the prior art Auxiliary request I: Amendments - supported by the application as filed (no) Auxiliary request II: Inventive step (yes) - non obvious solution |
||||||||
| Catchwords: |
1. Article 69 EPC and its Protocol on interpretation do not provide a basis for excluding what is literally covered by the terms of a claim (see point 3.5 of the reasons). |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t050223eu1.html
Date retrieved: 17 May 2021